Literature DB >> 2509103

Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial.

K P Rentrop1, F Feit, W Sherman, J C Thornton.   

Abstract

In the Second Mt. Sinai-New York University Reperfusion Trial, in which change of ejection fraction was the primary end point, the following secondary end points were prospectively assessed by serial coronary angiography: patency of the infarct artery both before intervention and 10-14 days later, acute and delayed recanalization rates, presence or absence of collateral flow, and complication rates of acute interventional catheterization. We assigned 393 patients randomly to groups receiving acute cardiac catheterization and a double-blind intracoronary infusion of streptokinase (SK arm), both streptokinase and nitroglycerin (SK-NTG arm), nitroglycerin alone (NTG arm), or conventional therapy without acute catheterization (control arm). Prospective stratification was based on duration of infarct pain before randomization: group A, less than 2 hours; Group B, 2-12 hours. Baseline patency rates were comparable in patients studied within 6 hours (30%, 40 of 135) and those studied later (24%, 32 of 133). This finding refutes the hypothesis that spontaneous recanalization occurs frequently after 6 hours. The acute recanalization rates of the SK arm (60%, 40 of 67) and the SK-NTG arm (63%, 29 of 62) did not differ. During streptokinase infusion, more vessels recanalized in group A (81%, 22 of 27) than in group B (56%, 57 of 102) (p less than 0.01); this was due to a significant reduction of recanalization rates from 75% (48 of 64) to 45% (26 of 62) with treatment after 6 hours (p less than 0.01). Delayed recanalization, that is, patency at end point but not postintervention, was seen in 17% (17 of 100) of total occlusions treated with streptokinase. In group A, all total occlusions treated with streptokinase recanalized either acutely (20 of 22) or delayed (two of 22), whereas in group B, 23% (18 of 78) remained obstructed. The reocclusion rate in the SK arms was 17% (11 of 65). In the NTG arm, recanalization occurred during intervention in 4% (two of 47) and delayed in 45% (21 of 47). At end-point angiography, the patency rates of the NTG arm (62%, 41 of 66) and the control arm (58%, 36 of 62) were comparable; those of the SK arms were higher (75%, 105 of 140) (p less than 0.01). Total occlusion was associated with collateral flow in 33% (66 of 199) at baseline; the prevalence of collaterals did not increase with time to angiography, which indicates that they had developed before the index event.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509103     DOI: 10.1161/01.cir.80.5.1166

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

Review 1.  Advances in thrombolytic therapy.

Authors:  M Verstraete
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

2.  Physiologic capacity of well-developed collaterals in patients with isolated left anterior descending artery disease.

Authors:  K Sakata; H Yoshida; N Ono; S Ohtani; N Mori; S Yokoyama; T Hoshino; T Kaburagi; C Kurata
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

3.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 4.  The role of mitochondrial bioenergetics and reactive oxygen species in coronary collateral growth.

Authors:  Yuh Fen Pung; Wai Johnn Sam; James P Hardwick; Liya Yin; Vahagn Ohanyan; Suzanna Logan; Lola Di Vincenzo; William M Chilian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

Review 5.  Vessel wall-related risk factors in acute vascular events.

Authors:  L Badimon; J J Badimon; M Cohen; J H Chesebro; V Fuster
Journal:  Drugs       Date:  1991       Impact factor: 9.546

6.  Does a waiting time for elective coronary angioplasty affect the primary success rate?

Authors:  K T Koch; J J Piek; G K David; K Mulder; R J Peters; K I Lie
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

7.  Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

8.  Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.

Authors:  D P de Bono; M L Simoons; J Tijssen; A E Arnold; A Betriu; C Burgersdijk; L López Bescos; E Mueller; M Pfisterer; F Van de Werf
Journal:  Br Heart J       Date:  1992-02

9.  Temporal patterns of blood flow and nitric oxide synthase expression affect macrophage accumulation and proliferation during collateral growth.

Authors:  Hendrik B Sager; Ralf Middendorff; Kim Rauche; Joachim Weil; Wolfgang Lieb; Heribert Schunkert; Wulf D Ito
Journal:  J Angiogenes Res       Date:  2010-09-16

10.  Impact of microvascular integrity and local viability on left ventricular remodelling after reperfused acute myocardial infarction.

Authors:  P Garot; O Pascal; M Simon; J L Monin; E Teiger; J Garot; P Guéret; J L Dubois-Randé
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.